风险持续评估报告

Search documents
华北制药股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-13 18:14
Group 1 - The company has released its semi-annual report for 2025, which includes important information regarding its operational results, financial status, and future development plans [1][5] - The board of directors and senior management have confirmed the authenticity, accuracy, and completeness of the report, taking legal responsibility for any false statements or omissions [1][3] - There is no profit distribution plan or capital reserve increase plan for the reporting period [1] Group 2 - The company held its 22nd meeting of the 11th board of directors on August 13, 2025, with all 9 directors present [4][6] - The meeting approved the full semi-annual report and its summary, which will be published in major financial newspapers and on the Shanghai Stock Exchange website [5][8] - The board also reviewed and approved a risk assessment report related to a financial subsidiary, with specific voting results noted [8][9]